Literature DB >> 10580581

Resistance of three immortalized human hepatocyte cell lines to acetaminophen and N-acetyl-p-benzoquinoneimine toxicity.

P McCloskey1, R J Edwards, R Tootle, C Selden, E Roberts, H J Hodgson.   

Abstract

BACKGROUND/AIMS: Acetaminophen toxicity in hepatocytes is attributed to generation of the toxic metabolite N-acetyl-p-benzoquinoneimine, leading to depletion of intracellular glutathione, alteration of redox potential and ultimately, cellular necrosis. We aimed to determine the effect of acetaminophen and N-acetyl-p-benzoquinoneimine on three human hepatocyte cell lines HH25, HH29 and HHY41, and for comparison, on primary rat hepatocytes, a cell type that is relatively resistant to acetaminophen-induced toxicity.
METHODS: We investigated the effect of incubation of rat hepatocytes and 3 hepatocyte cell lines with acetaminophen or N-acetyl-p-benzoquinoneimine on LDH release, glutathione status, mitochondrial function, CYP1A activity, albumin synthesis and DNA content.
RESULTS: We demonstrated that HH25, HH29 and HHY41 are resistant to the toxic effects of acetaminophen under conditions that induce cytotoxicity in rat primary hepatocytes, as indicated by maintenance of glutathione levels and basal LDH release. Incubation with N-acetyl-p-benzoquinoneimine caused a dose-dependent cytotoxicity in rat hepatocytes. Under comparable conditions N-acetyl-p-benzoquinoneimine had no effect on any of the hepatocyte cell lines. Nevertheless, when culturing the cells for a further 48 h, a decrease in glutathione levels, albumin synthesis, CYP1A activity, DNA content and mitochondrial function was apparent.
CONCLUSION: HH25, HH29 and HHY41 cells are highly resistant to acetaminophen and N-acetyl-p-benzoquinoneimine-induced toxicity. They tolerate a much higher concentration of both toxins for a longer period of time compared to rat primary hepatocytes. These results are of relevance in the use of these cell lines to investigate acetaminophen hepatotoxicity, and may be of importance in the choice of cells for use in bioartificial liver support systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580581     DOI: 10.1016/s0168-8278(99)80285-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

Review 1.  Prospects for extracorporeal liver support.

Authors:  R Jalan; S Sen; R Williams
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

2.  Anti-lipid peroxidation and protection of liver mitochondria against injuries by picroside II.

Authors:  Hua Gao; Ya-Wei Zhou
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 3.  Artificial liver support at present and in the future.

Authors:  Kazuhiko Onodera; Hiromi Sakata; Motoki Yonekawa; Akio Kawamura
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

4.  Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression.

Authors:  Xia Chen; Chang-Kai Sun; Guo-Zhu Han; Jin-Yong Peng; Ying Li; Yan-Xia Liu; Yuan-Yuan Lv; Ke-Xin Liu; Qin Zhou; Hui-Jun Sun
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

5.  Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues.

Authors:  Cheri Y Li; Kelly R Stevens; Robert E Schwartz; Brian S Alejandro; Joanne H Huang; Sangeeta N Bhatia
Journal:  Tissue Eng Part A       Date:  2014-04-28       Impact factor: 3.845

6.  A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.

Authors:  Clare Selden; James Bundy; Eloy Erro; Eva Puschmann; Malcolm Miller; Delawir Kahn; Humphrey Hodgson; Barry Fuller; Jordi Gonzalez-Molina; Aurelie Le Lay; Stephanie Gibbons; Sherri Chalmers; Sunil Modi; Amy Thomas; Peter Kilbride; Agnes Isaacs; Richard Ginsburg; Helen Ilsley; David Thomson; Galya Chinnery; Ncedile Mankahla; Lizel Loo; C Wendy Spearman
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.